Glenn E Nedwin

Title: Glenn E Nedwin: Innovator in Recombinant Lymphotoxin Research

Introduction

Glenn E Nedwin is a prominent inventor based in Guilford, CT (US), known for his significant contributions to the field of biotechnology. He holds three patents that focus on the synthesis and purification of biologically active lymphotoxin polypeptides. His work has paved the way for advancements in therapeutic applications of lymphotoxins.

Latest Patents

Nedwin's latest patents include innovative methods for synthesizing recombinant lymphotoxin polypeptides in cell culture. These patents provide novel nucleic acids and vectors that facilitate the economical preparation of uniform lymphotoxin polypeptides and variants with amino acid sequences differing from those found in nature. The purification processes he developed achieve a specific activity of 2-10×10^7 units/mg of protein, utilizing a unique immobilized, lymphotoxin-neutralizing monoclonal antibody.

Career Highlights

Glenn E Nedwin has made significant strides in his career, particularly through his work at Genentech, Inc. His research has contributed to the understanding and application of lymphotoxins in various therapeutic contexts. His innovative approaches have garnered attention in the scientific community, establishing him as a key figure in biotechnology.

Collaborations

Throughout his career, Nedwin has collaborated with notable scientists, including Bharat B Aggarwal and Patrick W Gray. These collaborations have further enhanced the impact of his research and innovations in the field.

Conclusion

Glenn E Nedwin's work in recombinant lymphotoxin research exemplifies the intersection of innovation and biotechnology. His patents and contributions continue to influence the development of therapeutic applications, showcasing the importance of his research in advancing medical science.